drugset / Trial / NCT04297813

Efficacy in Alveolar Bone Regeneration With Autologous MSCs and Biomaterial in Comparison to Autologous Bone Grafting

NCT04297813

RandomizedParallel-groupOpen-labelTreatment

Summary

A randomized controlled clinical multi center trial to assess the efficacy of a combination of autologous mesenchymal stem cells and biomaterial in jaw bone regeneration prior to dental implant placement in comparison to standard autologous bone block grafting.

Timeline

Start
2020-03-12
Primary completion
2023-07-31
Completion
2024-07-31

Drugs

EvaluationDrugModalityDoseRoute
Subject mesenchymal stem cells Cell therapy

Indications